JW Pharmaceutical Corp Free Cash Flow Generation Index
JW Pharmaceutical Corp free cash flow generation index. JW Pharmaceutical Corp (001065) has a Free Cash Flow Generation Index of 0.89x as of June 2026. Free cash flow of ₩37.98 Billion represents 1% of operating cash flow (₩42.51 Billion).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of JW Pharmaceutical Corp (2014–2025)
Free cash flow generation index of JW Pharmaceutical Corp from 2014 to 2025. Historical FCF Generation Index trend for JW Pharmaceutical Corp across 11 annual periods. See 001065 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
JW Pharmaceutical Corp Free Cash Flow Generation Index by Year (2014–2025)
JW Pharmaceutical Corp free cash flow generation index by year from 2014 to 2025. Year-by-year Free Cash Flow Generation Index for JW Pharmaceutical Corp. For the full cash flow conversion analysis, see 001065 cash flow conversion.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.63x | ₩60.28 Billion | ₩96.40 Billion | ₩36.12 Billion | ▼ -3.1% |
| 2024 | 0.65x | ₩51.25 Billion | ₩79.39 Billion | ₩28.14 Billion | ▲ +21.1% |
| 2023 | 0.53x | ₩46.45 Billion | ₩87.16 Billion | ₩40.71 Billion | ▼ -31.9% |
| 2022 | 0.78x | ₩44.41 Billion | ₩56.76 Billion | ₩9.92 Billion | ▲ +171.5% |
| 2021 | 0.29x | ₩5.22 Billion | ₩18.12 Billion | ₩7.47 Billion | ▼ -62.2% |
| 2020 | 0.76x | ₩48.02 Billion | ₩63.05 Billion | ₩12.39 Billion | ▼ -0.3% |
| 2019 | 0.76x | ₩42.43 Billion | ₩55.53 Billion | ₩9.28 Billion | ▼ -9.0% |
| 2018 | 0.84x | ₩43.76 Billion | ₩52.11 Billion | ₩8.64 Billion | ▲ +24.9% |
| 2017 | 0.67x | ₩22.50 Billion | ₩33.45 Billion | ₩7.50 Billion | ▼ -73.0% |
| 2016 | 2.49x | ₩16.76 Billion | ₩6.74 Billion | ₩10.02 Billion | ▲ +27.4% |
| 2014 | 1.95x | ₩14.21 Billion | ₩7.28 Billion | ₩6.93 Billion | — |